CoChat

Patient Adherence to Osteoporosis Medications: Problems, Consequences and Management Strategies

Papaioannou, Alexandra, Kennedy, Courtney C, Dolovich, Lisa, Lau, Elaine, Adachi, Jonathan D · 2007 · Drugs & Aging

The DOI matches its Crossref record; 88 of the 90 references it cites were found in a registry or an index.

Abstract

Adherence to osteoporosis medications is relatively poor. Approximately 20-30% of patients taking daily or weekly treatments may suspend their treatment within 6 to 12 months of initiating therapy. Patients with poor adherence increase their risk of osteoporotic fractures and hospitalisation. The majority of patients who discontinue therapy appear to do so because of drug-induced adverse effects. Fear of adverse effects or other health risks is another commonly cited reason for discontinuing therapy. Factors associated with medication adherence include fractures, regular exercise, female sex, fewer non-osteoporosis medications and co-morbidities, early menopause, willingness to take medications, awareness of osteoporosis status based on a diagnostic test, anti-inflammatory therapy and corticosteroid therapy. Factors associated with non-adherence include adverse effects, pain and being unsure about bone mineral density (BMD) test results. Bisphosphonates, a common class of drugs for treating osteoporosis, have specific administration requirements (e.g. fasting, remaining upright and not ingesting other medications concomitantly). Patient surveys indicate that 12-18% of patients report non-compliance with at least one administration rule. Strategies to increase adherence include reducing administration frequency to weekly or monthly, monitoring patients with bone markers and BMD testing, providing adequate instructions, practitioner feedback and support, and educational materials and sessions. Future studies are needed regarding strategies to increase adherence to osteoporosis medications.

Overview

Integrity signals

Registry

Crossref · 10.2165/00002512-200724010-00003

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 88 references

Research works printed but not linked: 5

  1. Haynes, 2005, Cochrane Database Syst Rev, 4, CD000011
  2. Segal, 2003, Isr Med Assoc J, 5, 859
  3. Lombas, 2001, J Bone Miner Res, 15, S529
  4. Pilon, 2001, Obstet Gynecol, 97, 97
  5. Morgan, 2004, Can J Clin Pharmacol, 11, e267

Cited by

See all 157

Metadata

Authors
Papaioannou, A., Kennedy, C. C., Dolovich, L., Lau, E., & Adachi, J. D.
Affiliations
  • McMaster University (CA)
  • St. Joseph’s Healthcare Hamilton (CA)
Venue
Drugs & Aging
Published
2007
Volume
24
Issue
1
Pages
37-55
ISSN
1170-229X (ISSN-L)
OpenAlex
W2043018151
Cited by
151
References
90
Citations by year
2026: 7 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 6 · 2014: 11 · 2013: 16 · 2012: 13
FWCI
1.59
Type
journal article
Language
en
Open access
closed
Locations
  • Drugs & Aging (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
Keywords
osteoporosis, medication adherence, treatment discontinuation, bisphosphonates, osteoporotic fractures, adverse drug reactions, bone densitometry, patient education, comorbidities, menopause, corticosteroid therapy, anti-inflammatory therapy
MeSH terms
Aged, Calcium, Diphosphonates, Drug Therapy, Combination, Female, Humans, Male, Osteoporosis, Patient Compliance, Vitamin D, Micronutrients, Hormone Replacement Therapy, Raloxifene Hydrochloride, Bone Density Conservation Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient Adherence to Osteoporosis Medications: Problems, Consequences and Management Strategies. https://app.cochat.ai/papers/10.2165/00002512-200724010-00003
The paper
Papaioannou, A., Kennedy, C. C., Dolovich, L., Lau, E., & Adachi, J. D. (2007). Patient Adherence to Osteoporosis Medications: Problems, Consequences and Management Strategies. Drugs & Aging. https://doi.org/10.2165/00002512-200724010-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.